Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03926065 · ClinicalTrials.gov registry record · NA
Variations in Palatability and Portion Size of Vegetables on Meal Intake of Preschool Children
A NA study, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT03926065: Completed NA study, sponsored by Penn State University.
NCT03926065 is a NA study that has completed, run by Penn State University. The registered enrollment target is 67 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03926065, a NA study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
The aim of the study is to determine the effect of varying both the palatability and portion size of vegetables served to preschool children at a meal on the outcomes of food and energy intake at the meal.
Primary Outcome
Weight of vegetables consumed at the meal (grams)
Interventions
- OTHER Plain Vegetables Served in 100% Portion Size
- OTHER Plain Vegetables Served in 200% Portion Size
- OTHER Enhanced Vegetables Served in 100% Portion Size
- OTHER Enhanced Vegetables Served in 200% Portion Size
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2019-05-28 |
| Est. Completion | 2019-10-29 |
| Phase | NA |
What the finished NCT03926065 record still lists
NCT03926065 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 4 interventions - of which Plain Vegetables Served in 100% Portion Size is the first listed.
NCT03926065 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03926065 about?
NCT03926065 is a clinical study titled "Variations in Palatability and Portion Size of Vegetables on Meal Intake of Preschool Children". The aim of the study is to determine the effect of varying both the palatability and portion size of vegetables served to preschool children at a meal on the outcomes of food and energy intake at the meal.
What is the current status of trial NCT03926065?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2019-05-28. Estimated completion is 2019-10-29.
What interventions are being tested in trial NCT03926065?
The interventions under investigation include: Plain Vegetables Served in 100% Portion Size (OTHER), Plain Vegetables Served in 200% Portion Size (OTHER), Enhanced Vegetables Served in 100% Portion Size (OTHER), Enhanced Vegetables Served in 200% Portion Size (OTHER).
Who is sponsoring clinical trial NCT03926065?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03926065's enrollment target sits among peer trials
67 1139th of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI